Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
09/26/1996 | WO1996029342A1 Lipophilic peptide hormone derivatives |
09/26/1996 | CA2215739A1 Lipophilic peptide hormone derivatives |
09/26/1996 | CA2215702A1 Thrombin inhibitors based on the amino acid sequence of hirudin |
09/25/1996 | EP0733213A1 Process for the production of combinatorial compound libraries |
09/25/1996 | EP0733206A1 Labelling of nucleic acid analogue-peptide chimerae |
09/25/1996 | EP0733123A1 Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
09/25/1996 | EP0733071A1 Antagonists to chaperonin 10 |
09/25/1996 | EP0733065A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
09/25/1996 | EP0733061A1 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents |
09/25/1996 | EP0733060A1 Metal chelators |
09/25/1996 | EP0732944A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
09/25/1996 | EP0732934A1 Long-acting injection suspensions and a process for their preparation |
09/25/1996 | EP0670751A4 Improved sensor membranes. |
09/25/1996 | EP0438566B1 Substance P antagonists |
09/25/1996 | CN1131950A Recombinant C140 receptor and its agonists and antagonists |
09/24/1996 | US5559028 Methods of enhancing or antigen presentation to T cells inhibiting |
09/24/1996 | US5559025 Expression of mature proteinase 2A, the partial purification thereof and preparation of substrates having an inhibitory effect |
09/19/1996 | WO1996028559A1 Method for the production of cationic peptides |
09/19/1996 | WO1996028471A1 Modulators of amyloid aggregation |
09/19/1996 | WO1996028468A2 Amphiphilic peptide and analogs thereof |
09/19/1996 | WO1996028467A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
09/19/1996 | WO1996028466A1 Peptides inhibiting phospholipase c |
09/19/1996 | CA2449296A1 Modulators of amyloid aggregation |
09/19/1996 | CA2215362A1 Method for the production of cationic peptides |
09/19/1996 | CA2189674A1 Peptides inhibiting phospholipase c |
09/18/1996 | EP0732399A2 Chymotrypsin-like proteases and their inhibitors |
09/18/1996 | EP0732339A1 Peptides of the HIV-gag protein, their preparation and use |
09/18/1996 | EP0731838A1 Binding structures directed against the ca55.1 antigen |
09/18/1996 | EP0731811A1 Chaperonin 10 |
09/18/1996 | EP0731810A1 Double-chain hemoregulatory peptides |
09/18/1996 | CN1131192A Recombinant mersacidin and method for production |
09/17/1996 | US5556836 Use of D-glucopyranuronic acids and their derivatives for incorporation in pharmacologically active peptides and their salts |
09/17/1996 | US5556762 Scanning synthetic peptide combinatorial libraries: oligopeptide mixture sets having a one predetermined residue at a single, predetermined position, methods of making and using the same |
09/17/1996 | US5556752 Solid supporrt with oligonucleotides, spacers, linking groups and double strands |
09/17/1996 | US5556609 Metal labled peptides for medical diagnosis of diseases |
09/12/1996 | WO1996027607A1 Process for preparation of pure cyclosporin chromatographically using an eluent consisting essentially of high pressure carbon dioxide |
09/12/1996 | WO1996027387A1 Identification of self and non-self antigens implicated in autoimmune disease |
09/12/1996 | WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
09/12/1996 | CA2189738A1 Identification of self and non-self antigens implicated in autoimmune disease |
09/11/1996 | EP0731110A1 Methods for the production of conformationally stabilized cell adhesion peptides |
09/11/1996 | EP0731106A1 Novel peptide derivative |
09/11/1996 | EP0730607A1 Novel integrin-binding peptides |
09/11/1996 | EP0730469A1 Modified truncated complement system regulators |
09/11/1996 | EP0730465A1 Use of angiotensin iii and analogs thereof in tissue repair |
09/11/1996 | EP0592564B1 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology |
09/11/1996 | EP0540574B1 Anticoagulant peptides |
09/11/1996 | EP0532650B1 Method of inducing plant defense mechanisms |
09/11/1996 | EP0372031B1 Biosynthetic osteogenic proteins and osteogenic devices containing them |
09/11/1996 | CN1130910A Hapten-marked peptides |
09/10/1996 | US5554728 Lipid conjugates of therapeutic peptides and protease inhibitors |
09/10/1996 | US5554724 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
09/10/1996 | US5554506 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
09/10/1996 | US5554501 Genetic analysis of patient samples |
09/10/1996 | CA2144264A1 Bombesin analogs |
09/06/1996 | WO1996026961A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
09/06/1996 | WO1996026950A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives |
09/06/1996 | CA2247207A1 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
09/06/1996 | CA2189358A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives |
09/04/1996 | EP0729974A1 Cyclic polypeptide with antibiotic activity and a process for preparation thereof |
09/04/1996 | EP0729972A1 Peptide derivatives of tetrahydronaphthalene |
09/04/1996 | EP0729360A1 Treatment or prevention of crohn's disease and/or ulcerative colitis |
09/04/1996 | CN1130210A Method for preparing cyclocyto polypeptide A from Branched layer wall bacterium |
09/03/1996 | US5552525 Radiodiagnostic reagents using peptides for detection of infections |
09/03/1996 | US5552521 Process for preparing certain aza cyclohexapeptides |
09/03/1996 | US5552520 Such as somatostatin analogs or bombesin analogs |
09/03/1996 | US5552384 Antiherpes compositions and method of use |
09/03/1996 | US5552383 Analgesic, antiinflammatory for wounds |
09/03/1996 | CA1338583C Process for the preparation of peptides by use of perchlorates |
08/29/1996 | WO1996026218A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
08/29/1996 | WO1996026214A1 Isolated nonapeptides presented by hla molecules, and uses thereof |
08/29/1996 | WO1996017937A3 Pesticidal composition comprising cryif chimeric and cryia(c) chimeric bacillus thuringiensis delta-endotoxin |
08/29/1996 | WO1996017869A3 Interleukin-6 (il-6) antagonists |
08/29/1996 | WO1996016172A3 Modulators of anchoring protein function |
08/29/1996 | CA2566828A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
08/29/1996 | CA2213337A1 Isolated nonapeptides presented by hla molecules, and uses thereof |
08/28/1996 | EP0728208A1 Tomato xyloglucan endo-transglycosylase |
08/28/1996 | EP0728201A1 Brain-derived membrane-associated crf binding proteins |
08/28/1996 | EP0728148A1 Improved immunogenic compositions against human gastrin 17 |
08/28/1996 | EP0728146A1 Conotoxin peptides |
08/28/1996 | EP0728012A1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF |
08/27/1996 | US5550183 Metal-peptide compositions and methods for stimulating hair growth |
08/27/1996 | US5550110 Pentapeptide and hexapeptide analogs of endothelin-1 |
08/27/1996 | US5549883 (oligo or poly)peptides |
08/22/1996 | WO1996025511A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF |
08/22/1996 | WO1996025435A1 MONOCLONAL ANTIBODY SPECIFIC FOR βA4 PEPTIDE |
08/22/1996 | WO1996025430A1 Helicobacter pylori antigen |
08/22/1996 | WO1996025175A1 ADMINISTRATION OF A CYCLOSPORINE-SPECIFIC MONOCLONAL ANTIBODY THAT CROSS-REACTS WITH HIV-1 p24 GAG TO TREAT HIV INFECTION |
08/22/1996 | CA2212952A1 Helicobacter pylori antigen |
08/21/1996 | EP0726954A1 Cntf family antagonists |
08/21/1996 | EP0726945A1 B1k CHAIN OF LAMININ AND METHODS OF USE |
08/21/1996 | EP0726910A1 Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparations containing these compounds |
08/21/1996 | EP0726758A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
08/20/1996 | US5547939 Broad spectrum antimicrobial compounds and methods of use |
08/20/1996 | US5547934 A polypeptide which acts as a fungicide and a protozoicide |
08/20/1996 | US5547871 Genetic engineering |
08/20/1996 | US5547846 Immunogenic regions on the E7 protein of human papillomavirus type 16 |
08/20/1996 | US5547839 Contacting polynucleotides with surface of solid substrate, hybridizing using nucleic acid polymerase and labeled nucleotide |
08/15/1996 | WO1996024675A1 GnRH-LEUKOTOXIN CHIMERAS |
08/15/1996 | WO1996024613A1 A process for preparing certain aza cyclohexapeptides |
08/15/1996 | WO1996024608A1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics |